Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Cleaver

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
JAMA Dermatology|September 5, 2014
The risk of melanoma in airline pilots and cabin crew: a meta-analysisMartina Sanlorenzo, Mackenzie R Wehner, Eleni Linos, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Targeting protein-trafficking pathways alters melanoma treatment sensitivityZhi-ming Huang, Milka Chinen, Philip J Chang, et al.
Cancer|August 12, 2020
Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging systemMohammed Kashani-Sabet, James R Miller, Serigne Lo, et al.
Cancer Research|March 26, 2021
Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation-Induced DNA Damage and Melanoma SusceptibilityDavid de Semir, Vladimir Bezrookove, Mehdi Nosrati, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2006
Genes and pathways downstream of telomerase in melanoma metastasisSepideh Bagheri, Mehdi Nosrati, Shang Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2018
PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancerDavid de Semir, Vladimir Bezrookove, Mehdi Nosrati, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanomaAltaf A Dar, Vladimir Bezrookove, Mehdi Nosrati, et al.
The Journal of Investigative Dermatology|June 13, 2002
Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patientsSteffen Emmert, Hanoch Slor, David B Busch, et al.
The Journal of Clinical Investigation|July 10, 2025
Combinatorial therapy regimens targeting preclinical models of melanoma resistant to immune checkpoint blockadeImran Khan, Aida Rodriguez-Brotons, Anukana Bhattacharjee, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2020
PHIP drives glioblastoma motility and invasion by regulating the focal adhesion complexDavid de Semir, Vladimir Bezrookove, Mehdi Nosrati, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
JAMA Dermatology|September 5, 2014
The risk of melanoma in airline pilots and cabin crew: a meta-analysisMartina Sanlorenzo, Mackenzie R Wehner, Eleni Linos, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Targeting protein-trafficking pathways alters melanoma treatment sensitivityZhi-ming Huang, Milka Chinen, Philip J Chang, et al.
Cancer|August 12, 2020
Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging systemMohammed Kashani-Sabet, James R Miller, Serigne Lo, et al.
Cancer Research|March 26, 2021
Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation-Induced DNA Damage and Melanoma SusceptibilityDavid de Semir, Vladimir Bezrookove, Mehdi Nosrati, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2006
Genes and pathways downstream of telomerase in melanoma metastasisSepideh Bagheri, Mehdi Nosrati, Shang Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2018
PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancerDavid de Semir, Vladimir Bezrookove, Mehdi Nosrati, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanomaAltaf A Dar, Vladimir Bezrookove, Mehdi Nosrati, et al.
The Journal of Investigative Dermatology|June 13, 2002
Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patientsSteffen Emmert, Hanoch Slor, David B Busch, et al.
The Journal of Clinical Investigation|July 10, 2025
Combinatorial therapy regimens targeting preclinical models of melanoma resistant to immune checkpoint blockadeImran Khan, Aida Rodriguez-Brotons, Anukana Bhattacharjee, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2020
PHIP drives glioblastoma motility and invasion by regulating the focal adhesion complexDavid de Semir, Vladimir Bezrookove, Mehdi Nosrati, et al.
Pageof 6